“An Amazing Year for Breast Cancer Research”


The San Antonio Breast Cancer Symposium draws breast cancer experts from around the world into one place to share the latest research and progress. . In this podcast, Erica L. Mayer, MD, MPH, discusses some of the highlights from the 2017 symposium, held last month.

  • A study examined who may or may not benefit from long-term hormone therapy to prevent the cancer from coming back [2:20].

  • The PARP inhibitor Talazoparib may be a new targeted therapy to treat metastatic breast cancer in people with a BRCA1 or BRCA2 gene mutation [4:20].

  • Antibody drug conjugates, a type of targeted therapy, helped shrink tumors in people with HER2-positive and triple-negative breast cancer [5:42].

  • Research in supportive care looked at relieving joint discomfort and stiffness with acupuncture in patients receiving aromatase inhibitors [7:22].

  • A treatment called “ovarian suppression” may help preserve fertility in young women with breast cancer who are receiving chemotherapy [8:40].

Dr. Mayer is the Cancer.Net Associate Editor for breast cancer.

This is a prerecorded audio podcast. It can be listened to online or downloaded to your computer. A transcript of this podcast is also available. For more information, visit the Cancer.Net podcast page.

Related posts

Leave a Comment